These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15459499)

  • 21. Expression of N-cadherin in esophageal squamous cell carcinoma and silencing expression of N-cadherin using RNA interference on invasiveness of EC9706 cells.
    Li K; Wang X; He W; Lin N; Fan QX
    Ai Zheng; 2009 Jan; 28(1):8-13. PubMed ID: 19448425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
    Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
    Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.
    Lascombe I; Clairotte A; Fauconnet S; Bernardini S; Wallerand H; Kantelip B; Bittard H
    Clin Cancer Res; 2006 May; 12(9):2780-7. PubMed ID: 16675571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
    Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
    Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.
    Ochiai H; Nakanishi Y; Fukasawa Y; Sato Y; Yoshimura K; Moriya Y; Kanai Y; Watanabe M; Hasegawa H; Kitagawa Y; Kitajima M; Hirohashi S
    Oncology; 2008; 75(1-2):32-41. PubMed ID: 18728370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
    Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ
    Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
    Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
    Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of thrombin receptor expression on microvessel endothelial cells, and survival by coagulation state in oesophageal squamous cell carcinoma.
    Shao Y; Xu QQ; Li C; Wu MY; Huang XY
    J Clin Pathol; 2012 Aug; 65(8):740-5. PubMed ID: 22685255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
    Zhu Y; Zhou XY; Yao XD; Dai B; Ye DW
    BJU Int; 2007 Jul; 100(1):204-8. PubMed ID: 17433031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression.
    Shimamura T; Sakamoto M; Ino Y; Sato Y; Shimada K; Kosuge T; Sekihara H; Hirohashi S
    J Clin Oncol; 2003 Feb; 21(4):659-67. PubMed ID: 12586803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
    Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
    J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    Zou J; Yang H; Chen F; Zhao H; Lin P; Zhang J; Ye H; Wang L; Liu S
    Eur J Cancer Prev; 2010 Jan; 19(1):11-7. PubMed ID: 19741544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.
    Yoshinaga K; Inoue H; Utsunomiya T; Sonoda H; Masuda T; Mimori K; Tanaka Y; Mori M
    Clin Cancer Res; 2004 Sep; 10(17):5702-7. PubMed ID: 15355896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.
    Uchikado Y; Natsugoe S; Okumura H; Setoyama T; Matsumoto M; Ishigami S; Aikou T
    Clin Cancer Res; 2005 Feb; 11(3):1174-80. PubMed ID: 15709186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma.
    Yoshida R; Morita M; Shoji F; Nakashima Y; Miura N; Yoshinaga K; Koga T; Tokunaga E; Saeki H; Oki E; Oda Y; Maehara Y
    Ann Surg Oncol; 2015 Aug; 22(8):2608-14. PubMed ID: 25564163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin.
    Batistatou A; Peschos D; Tsanou H; Charalabopoulos A; Nakanishi Y; Hirohashi S; Agnantis NJ; Charalabopoulos K
    Br J Cancer; 2007 May; 96(9):1404-8. PubMed ID: 17437014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.